Evidence map›Paper›PMID 35897906›Full record

ArticleMolecules (Basel, Switzerland)2022

Neocornuside A-D, Four Novel Iridoid Glycosides from Fruits of

Meng Yang, Zhiyou Hao, Xiaolan Wang, Shiqi Zhou, Denghui Zhu, Ying Yang, Junjun Wei, Meng Li, Xiaoke Zheng, Weisheng Feng

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Molecules (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Meng YangSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
Zhiyou HaoSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
Xiaolan WangThe Engineering and Technology Center for Chinese Medicine Development of Henan Province China, Zhengzhou 450046, China.
Shiqi ZhouSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
Denghui ZhuSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
Ying YangSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
Junjun WeiSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
Meng LiSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.ORCID 0000-0002-9633-9257
Xiaoke ZhengSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
Weisheng FengSchool of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
Henan Bioengineering Technology Research Center · CN

Funding

Central Government Guide Local Science and Technology Development Special Foundation [2016]149Henan Province High-level Personnel Special Support ZYQR201810080Key Projects for Science and Technology Development of Henan Province 212102311091
6 · The paper itself

Abstract

Four previously undescribed iridoid glycosides neocornuside A-D (

Indexed as

CornusInsulinsFruitGlycosidesHypoglycemic AgentsIridoid GlycosidesGlycosidesHypoglycemic AgentsInsulinsIridoid Glycosidesantidiabetic activityCornus officinalisiridoid glycosidesstructure elucidation

Identifiers

PMID35897906
PMCPMC9331380
OpenAlexW4287147966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.